Belzutifan improves PFS, ORR in clear cell renal cell carcinoma

Nivolumab plus gemcitabine-cisplatin shows benefit for locally advanced mUC

Belzutifan cabozantinib combo shows durable anti-tumour effect at phase II for ccRCC

Myeloma treatment and prognosis

Imaging and intervention in thyroid lesions

OncoAlert Round Up for September 22-28, 2023

OncoAlert Round Up for September 15-21, 2023

OncoAlert Round Up for September 8-14, 2023

OncoAlert Round Up for September 1-7, 2023

Part 6: Which different PARP inhibitors are available

Part 7: Similarities and Differences

Part 8: How PARP inhibitors are being used now